Alkermes Plc is a company in the U.S. stock market and it is a holding in 58 U.S.-traded ETFs. ALKS has around 15.9M shares in the U.S. ETF market. The largest ETF holder of ALKS is the First Trust NYSE Arca Biotechnology Index Fund (FBT), with approximately 3.98M shares. Investors may also find of interest that the ETF with the largest allocation to ALKS stock is First Trust NYSE Arca Biotechnology Index Fund (FBT), with a portfolio weight of 3.61%. On average, U.S. ETFs allocate 0.27% of ALKS to their portfolios.
Additionally, ALKS is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALKS as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 39.80%.